Luo M - Search Results

1

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo.

Fan Y, Tao T, Guo Z, Wah To KK, Chen D, Wu S, Yang C, Li J, Luo M, Wang F, Fu L. Fan Y, et al. Among authors: luo m. Mol Ther Oncolytics. 2022 Feb 16;24:636-649. doi: 10.1016/j.omto.2022.02.006. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35284628 Free PMC article.

2

Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.

Luo M, Fu LW. Luo M, et al. Am J Cancer Res. 2014 Nov 19;4(6):608-28. eCollection 2014. Am J Cancer Res. 2014. PMID: 25520855 Free PMC article. Review.

3

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response.

Luo M, Fu L. Luo M, et al. Oncotarget. 2016 May 17;7(20):29794-803. doi: 10.18632/oncotarget.7631. Oncotarget. 2016. PMID: 26919108 Free PMC article. Review.

4

Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Liang SB, Teng JJ, Hu XF, Yang XL, Luo M, Fang XN, Liu DS, Chen Y, Fu LW. Liang SB, et al. Among authors: luo m. BMC Cancer. 2017 Jul 28;17(1):506. doi: 10.1186/s12885-017-3480-5. BMC Cancer. 2017. PMID: 28754109 Free PMC article.

5

PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis.

Fang X, Xie H, Luo M, Chen Z, Wang F, Li Q, Wang X, Ding J, Fu L. Fang X, et al. Among authors: luo m. Biochem Pharmacol. 2018 Apr;150:131-140. doi: 10.1016/j.bcp.2018.01.051. Epub 2018 Feb 3. Biochem Pharmacol. 2018. PMID: 29408327

6

Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.

Guo X, To KKW, Chen Z, Wang X, Zhang J, Luo M, Wang F, Yan S, Fu L. Guo X, et al. Among authors: luo m. J Exp Clin Cancer Res. 2018 Feb 20;37(1):31. doi: 10.1186/s13046-018-0690-x. J Exp Clin Cancer Res. 2018. PMID: 29458405 Free PMC article.

7

Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.

Yang L, Li M, Wang F, Zhen C, Luo M, Fang X, Zhang H, Zhang J, Li Q, Fu L. Yang L, et al. Among authors: luo m. Cell Physiol Biochem. 2018;46(6):2487-2499. doi: 10.1159/000489655. Epub 2018 May 5. Cell Physiol Biochem. 2018. PMID: 29742496 Free article.

8

Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo.

Zhang Z, Guo X, To KKW, Chen Z, Fang X, Luo M, Ma C, Xu J, Yan S, Fu L. Zhang Z, et al. Among authors: luo m. Acta Pharm Sin B. 2018 Jul;8(4):563-574. doi: 10.1016/j.apsb.2018.06.002. Epub 2018 Jun 15. Acta Pharm Sin B. 2018. PMID: 30109181 Free PMC article.

9

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.

Luo F, Luo M, Rong QX, Zhang H, Chen Z, Wang F, Zhao HY, Fu LW. Luo F, et al. Among authors: luo m. J Immunother Cancer. 2019 Sep 11;7(1):245. doi: 10.1186/s40425-019-0733-7. J Immunother Cancer. 2019. PMID: 31511071 Free PMC article.

10

Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer.

Luo M, Wang F, Zhang H, To KKW, Wu S, Chen Z, Liang S, Fu L. Luo M, et al. Signal Transduct Target Ther. 2020 Aug 28;5(1):141. doi: 10.1038/s41392-020-0200-4. Signal Transduct Target Ther. 2020. PMID: 32855386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,955 results

Search Page

Filters